# ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/araf-amplification-in-small-cell-lung-cancer-transformed-tumors-following/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ryo Kimura,Yuta Adachi,Kentaro Hirade,Satoru Kisoda,Shogo Yanase,Norio Shibata,Makoto Ishii,Yutaka Fujiwara,Rui Yamaguchi,Yasuko Fujita,Waki Hosoda,Hiromichi Ebi |
| Citations | 0 |
| DOI | 10.3390/cancers16203501 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/2072-6694/16/20/3501/pdf?version=1729090323 |
| OpenAlex ID | https://openalex.org/W4403450011 |
| PMID | 39456595 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Makoto Ishii](https://scholariq.org/researchers/makoto-ishii/)
- [Yutaka Fujiwara](https://scholariq.org/researchers/yutaka-fujiwara/)
- [Norio Shibata](https://scholariq.org/researchers/norio-shibata/)
- [Rui Yamaguchi](https://scholariq.org/researchers/rui-yamaguchi/)
- [Hiromichi Ebi](https://scholariq.org/researchers/hiromichi-ebi/)

## Paper funders

Showing 8 of 19.

- [Amgen](https://scholariq.org/funders/amgen/)
- [Bristol-Myers Squibb](https://scholariq.org/funders/bristol-myers-squibb/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [GlaxoSmithKline](https://scholariq.org/funders/glaxosmithkline/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [Merck KGaA](https://scholariq.org/funders/merck-kgaa/)

## Paper journal

- [Cancers](https://scholariq.org/journals/cancers/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.